tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Apimeds Pharmaceuticals US Inc

APUS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.900USD
+0.005+0.58%
์ข…๊ฐ€ย 07/02, 13:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
11.32M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
์ƒ์„ธ ์ฐจํŠธ ๋ณด๊ธฐ
TradingKey ๅ›พ่กจ
Intraday
1m
30m
1h
D
W
M
D

์˜ค๋Š˜

+0.58%

5์ผ

0.00%

1๊ฐœ์›”

-36.17%

6๊ฐœ์›”

-45.95%

์˜ฌํ•ด ํ˜„์žฌ๊นŒ์ง€

-45.12%

1๋…„

-49.44%

ํ•ต์‹ฌ ์ˆ˜์น˜
0.932์‹œ๊ฐ€
0.950์ตœ๊ณ ๊ฐ€
188.93K๊ฑฐ๋ž˜๋Ÿ‰
์†์‹คP/E TTM
--๋™์  P/E ๋น„์œจ
--๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
1.50%ํšŒ์ „์œจ
0.885์ „์ผ ์ข…๊ฐ€
0.861์ตœ์ €๊ฐ€
127.94K๋งค์ถœ์•ก
์†์‹ค์ฃผ๊ฐ€์ˆ˜์ต๋น„์œจ
0.09P/B
0.00%๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
-7.31%ROA
4.03152์ฃผ ์ตœ๊ณ ๊ฐ€
1.13๊ฑฐ๋ž˜๋Ÿ‰ ๋น„์œจ
-1.39M์ˆœ์ด์ต
12.58M์ฃผ์‹
-0.5515์ฃผ๋‹น์ˆœ์ด์ต
--๋ฒ ํƒ€
-7.90%ROE
0.95152์ฃผ ์ตœ์ €๊ฐ€
10.07%๋ณ€๋™ ํญ
--์ด ์ด์ต๋ฅ 
11.32M์‹œ๊ฐ€์ด์•ก
-3.98๋ณด์ƒ/์œ„ํ—˜
9.34%์œ„ํ—˜๋ฅ 

TradingKey ์ฃผ์‹ ์ ์ˆ˜

๋ฐ์ดํ„ฐ๊ฐ€ ๋ถ€์กฑํ•˜์—ฌ ์ฃผ์‹ ์ ์ˆ˜๋ฅผ ํ™•์ธํ•  ์ˆ˜ ์—†์Šต๋‹ˆ๋‹ค.

Apimeds Pharmaceuticals US Inc ๋‰ด์Šค

๋” ๋งŽ์€ ๋‰ด์Šค๊ฐ€ ๊ณง ์—…๋ฐ์ดํŠธ๋ฉ๋‹ˆ๋‹ค. ๊ณ„์† ์ง€์ผœ๋ด ์ฃผ์„ธ์š”โ€ฆ

์žฌ๋ฌด ์ง€ํ‘œ๎˜

EPS

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ด ์ˆ˜์ต

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

Apimeds Pharmaceuticals US Inc ์ •๋ณด๎˜

Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
์ข…๋ชฉ ์ฝ”๋“œ APUS
ํšŒ์‚ฌApimeds Pharmaceuticals US Inc
CEOMenon (Vin)
์›น์‚ฌ์ดํŠธhttps://www.apimedsus.com/

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Apimeds Pharmaceuticals US Inc(APUS)์˜ ํ˜„์žฌ ๊ฐ€๊ฒฉ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Apimeds Pharmaceuticals US Inc(APUS)์˜ ํ˜„์žฌ ์ฃผ๊ฐ€๋Š” 0.90์ž…๋‹ˆ๋‹ค.

Apimeds Pharmaceuticals US Inc์˜ ์ข…๋ชฉ ๊ธฐํ˜ธ(Symbol)๋Š” ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
Apimeds Pharmaceuticals US Inc์˜ ์ข…๋ชฉ ์ฝ”๋“œ๋Š” APUS์ž…๋‹ˆ๋‹ค.

Apimeds Pharmaceuticals US Inc์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Apimeds Pharmaceuticals US Inc์˜ 52์ฃผ ์ตœ๊ณ ๊ฐ€๋Š” 4.03์ž…๋‹ˆ๋‹ค.

Apimeds Pharmaceuticals US Inc์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Apimeds Pharmaceuticals US Inc์˜ 52์ฃผ ์ตœ์ €๊ฐ€๋Š” 0.95์ž…๋‹ˆ๋‹ค.

Apimeds Pharmaceuticals US Inc์˜ ์‹œ๊ฐ€์ด์•ก์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Apimeds Pharmaceuticals US Inc์˜ ์‹œ๊ฐ€์ด์•ก์€ 11.32M์ž…๋‹ˆ๋‹ค.

Apimeds Pharmaceuticals US Inc(APUS)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Apimeds Pharmaceuticals US Inc(APUS)์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS TTM)์€ -0.55์ž…๋‹ˆ๋‹ค.